Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer
IntroductionIdentification of effective therapies for colorectal cancer (CRC) remains an urgent medical need, especially for the microsatellite stable (MSS) phenotype. In our previous study, potassium oxonate (PO), a uricase inhibitor commonly used for elevating uric acid in mice, unexpectedly showe...
Saved in:
Main Authors: | Yuanyuan Wang, Chenxi Hu, Tianpeng Du, Jiawen Li, Kaiyuan Hui, Xiaodong Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1528004/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice
by: Yuanyuan Wang, et al.
Published: (2025-02-01) -
Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
by: Yonghua Cai, et al.
Published: (2025-02-01) -
Enhancing counterfeit RFID tag classification through distance based cognitive risk control
by: Haifeng Wu, et al.
Published: (2025-02-01) -
Intake of sodium and potassium, sodium-potassium intake ratio, and their relation to the risk of diabetes mellitus
by: Sung Keun Park, et al.
Published: (2025-02-01) -
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
by: Guochen Li, et al.
Published: (2025-02-01)